ArticleScientific reports2025
In vitro antidiabetic and antioxidant activities of protein hydrolysates via alkaline autolysis of Fusarium venenatum mycoprotein.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancement of Phenolic Content and Antioxidant Capacity in Chiffon Cake Through Partial Replacement of Low-Gluten Flour with Mycoprotein Powder.Foods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mycoprotein from Fusarium venenatum, characterized by its abundant proteins could be a valuable candidate for autolysis, potentially contributing in the production of bioactive compounds. In this study, four autolysis methods, including acidic, alkaline, plasmolysis, and enzymatic hydrolysis were applied to enhance the extraction of bioactive compounds. The resulting protein hydrolysates were evaluated for their antioxidant properties, α-amylase and α-glucosidase inhibition, antibacterial activity against Escherichia coli, Salmonella spp., and Staphylococcus aureus, antifungal activity against Aspergillus niger, and structural characteristics. Antioxidant assays revealed that alkaline autolysates exhibited the highest activity (DPPH: ~ 556 µmol Trolox/g sample; ABTS: ~ 235 µmol Trolox/g sample), demonstrating approximately twice the inhibitory capacity compared to mycoprotein. The inhibitory effect on α-amylase was attributed to the porous structure of mycoprotein, which led to substantial physical entrapment of the enzyme (~ 62%). In contrast, α-glucosidase inhibition was primarily associated with the degree of hydrolysis and peptide structure, with alkaline autolysates (~ 35%) exhibiting the highest inhibitory activity. These findings suggest that α-glucosidase inhibition is likely due to structural interactions altering enzyme function, whereas α-amylase inhibition results from a physical entrapment mechanism. Despite their strong antioxidant and enzyme-inhibitory properties, neither mycoprotein nor the protein hydrolysates exhibited significant antimicrobial activity. These findings indicate that alkaline lysis of mycoprotein could serve as a source of bifunctional compounds with natural antioxidant and antidiabetic properties, making them valuable for the development of functional food formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.